Skip to search formSkip to main contentSkip to account menu

eculizumab Injection [Soliris]

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

30 ML eculizumab 10 MG/ML Injection [Soliris]
Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)
  • 2018
  • Corpus ID: 53454990
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that researchers presented data… 
2018
2018
Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the European Union (EU)
  • 2018
  • Corpus ID: 52262136
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the submission of a Marketing… 
2016
2016
Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field
The orphan drug eculizumab (Soliris ®) is one of the most expensive in the world and based on expenditures is classed among the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)